{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:32:29Z","timestamp":1793395949952,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>To compare the efficacy and safety of bioresorbable vascular stents (BVS) and drug-eluting stents (DES) in coronary heart disease.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The full text of clinical studies involving BVS and DES was retrieved in PubMed, Springer, EMBASE, Wiley-Blackwell, and Chinese Journal Full-text Database. Review Manager 5.3 was used for meta-analysis to evaluate the risk of target lesion failure, stent thrombosis and cardiac death in BVS and DES.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Finally, 10 studies with 6383 patients were included in the meta-analysis. Compared with DES group, BVS group had significantly increased risk of target lesion failure (OR\u2009=\u20091.46, 95%CI 1.20\u20131.79, <jats:italic>P<\/jats:italic>\u00a0=\u20090.0002; P <jats:sub>Heterogeneity<\/jats:sub>\u00a0=\u20090.68, I<jats:sup>2<\/jats:sup>\u00a0=\u20090%), stent thrombosis (OR\u2009=\u20092.70, 95%CI 1.57\u20134.66, <jats:italic>P<\/jats:italic>\u00a0=\u20090.0003; P <jats:sub>Heterogeneity<\/jats:sub>\u00a0=\u20091.00, I<jats:sup>2<\/jats:sup>\u00a0=\u20090%) and cardiac death (OR\u2009=\u20092.19, 95%CI 1.17\u20134.07, <jats:italic>P<\/jats:italic>\u00a0=\u20090.01; P <jats:sub>Heterogeneity<\/jats:sub>\u00a0=\u20090.93, I<jats:sup>2<\/jats:sup>\u00a0=\u20090%).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This study shows that DES is a safer treatment than BVS for coronary revascularization.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13019-020-1041-5","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T08:02:39Z","timestamp":1580198559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Bioresorbable vascular stents and drug-eluting stents in treatment of coronary heart disease: a meta-analysis"],"prefix":"10.1186","volume":"15","author":[{"given":"Le","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhurong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,28]]},"reference":[{"key":"1041_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ijscr.2016.02.035","volume":"21","author":"G Arturo","year":"2016","unstructured":"Arturo G, et al. Successful treatment of recurrent carotid in-stent restenosis and drug-eluting balloon failure with a coronary bioresorbable vascular scaffold: a case report. Int J Surg Case Rep. 2016;21:78\u201382.","journal-title":"Int J Surg Case Rep"},{"issue":"7","key":"1041_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/MCA.0000000000000141","volume":"25","author":"W Chan","year":"2014","unstructured":"Chan W, et al. Complex coronary artery bifurcation treatment utilizing everolimus-eluting bioresorbable vascular scaffolds and optical coherence tomography. Coron Artery Dis. 2014;25(7):629\u201331.","journal-title":"Coron Artery Dis"},{"issue":"1","key":"1041_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12872-016-0296-1","volume":"16","author":"D Dalos","year":"2016","unstructured":"Dalos D, et al. Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent. BMC Cardiovasc Disord. 2016;16(1):104.","journal-title":"BMC Cardiovasc Disord"},{"issue":"9","key":"1041_CR4","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.4244\/EIJV7I9A168","volume":"7","author":"D Dudek","year":"2012","unstructured":"Dudek D, et al. Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial. EuroIntervention. 2012;7(9):1060\u20131.","journal-title":"EuroIntervention"},{"issue":"1","key":"1041_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.carrev.2015.09.002","volume":"17","author":"H Nef","year":"2016","unstructured":"Nef H, et al. Evaluation of the short- and long-term safety and therapy outcomes of the everolimus-eluting bioresorbable vascular scaffold system in patients with coronary artery stenosis: rationale and design of the German-Austrian ABSORB RegIstRy (GABI-R). Cardiovasc Revasc Med. 2016;17(1):34\u20137.","journal-title":"Cardiovasc Revasc Med"},{"issue":"3","key":"1041_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2217\/fca.14.14","volume":"10","author":"A Ielasi","year":"2014","unstructured":"Ielasi A, Tespili M. Current and future perspectives on drug-eluting bioresorbable coronary scaffolds. Futur Cardiol. 2014;10(3):409\u201320.","journal-title":"Futur Cardiol"},{"issue":"47","key":"1041_CR7","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1093\/eurheartj\/ehv435","volume":"36","author":"T Kimura","year":"2015","unstructured":"Kimura T, et al. A randomized trial evaluating everolimus-eluting absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan. Eur Heart J. 2015;36(47):3332\u201342.","journal-title":"Eur Heart J"},{"issue":"6","key":"1041_CR8","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jcin.2015.12.004","volume":"9","author":"AMP Abizaid","year":"2016","unstructured":"Abizaid AMP, et al. Serial multimodality imaging and 2-year clinical outcomes of the novel DESolve Novolimus-eluting Bioresorbable coronary scaffold system for the treatment of single De novo coronary lesions. J Am Coll Cardiol Intv. 2016;9(6):565\u201374.","journal-title":"J Am Coll Cardiol Intv"},{"issue":"6","key":"1041_CR9","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s10554-011-9981-4","volume":"28","author":"S Brugaletta","year":"2012","unstructured":"Brugaletta S, et al. Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold. Int J Cardiovasc Imaging. 2012;28(6):1307\u201314.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"20","key":"1041_CR10","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","volume":"373","author":"SG Ellis","year":"2015","unstructured":"Ellis SG, et al. Everolimus-eluting Bioresorbable scaffolds for coronary artery disease. N Engl J Med. 2015;373(20):1905\u201315.","journal-title":"N Engl J Med"},{"key":"1041_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.colsurfb.2018.10.014","volume":"173","author":"L Huang","year":"2019","unstructured":"Huang L, et al. Hemocompatibility and anti-fouling behavior of multilayer biopolymers immobilized on gold-thiolized drug-eluting cardiovascular stents. Colloids Surf B: Biointerfaces. 2019;173:470\u20137.","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"1041_CR12","first-page":"574","volume":"15","author":"DW Kim","year":"2018","unstructured":"Kim DW, Her SH, Park HW. Incremental age-related one-year MACCE after acute myocardial infarction in the drug-eluting stent era (from KAMIR-NIH registry). J Geriatr Cardiol. 2018;15:574\u201384.","journal-title":"J Geriatr Cardiol"},{"key":"1041_CR13","first-page":"523","volume":"15","author":"YH Kim","year":"2018","unstructured":"Kim YH, Her AY, Rha SW. Five-year major clinical outcomes between first-generation and second- generation drug-eluting stents in acute myocardial infarction patients underwent percutaneous coronary intervention. J Geriatr Cardiol. 2018;15:523\u201333.","journal-title":"J Geriatr Cardiol"},{"issue":"8","key":"1041_CR14","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jacc.2014.12.017","volume":"65","author":"S Puricel","year":"2015","unstructured":"Puricel S, et al. Comparison of Everolimus- and Biolimus-eluting coronary stents with Everolimus-eluting Bioresorbable vascular scaffolds. J Am Coll Cardiol. 2015;65(8):791\u2013801.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1041_CR15","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jjcc.2017.03.007","volume":"70","author":"T Sato","year":"2017","unstructured":"Sato T, et al. The fate of incomplete scaffold apposition of everolimus-eluting bioresorble scaffolds: a serial optical coherence tomography analysis. J Cardiol. 2017;70(5):454\u201360.","journal-title":"J Cardiol"},{"issue":"9962","key":"1041_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0140-6736(14)61455-0","volume":"385","author":"PW Serruys","year":"2015","unstructured":"Serruys PW, et al. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial. Lancet. 2015;385(9962):43\u201354.","journal-title":"Lancet"},{"issue":"10157","key":"1041_CR17","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/S0140-6736(18)32283-9","volume":"392","author":"GW Stone","year":"2018","unstructured":"Stone GW, et al. Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial. Lancet. 2018;392(10157):1530\u201340.","journal-title":"Lancet"},{"issue":"S1","key":"1041_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/ccd.26810","volume":"88","author":"DG Rizik","year":"2016","unstructured":"Rizik DG, Hermiller JB, Kereiakes DJ. Bioresorbable vascular scaffolds for the treatment of coronary artery disease: clinical outcomes from randomized controlled trials. Catheter Cardiovasc Interv. 2016;88(S1):21\u201330.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"12 Suppl 4","key":"1041_CR19","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.3949\/ccjm.84.s4.05","volume":"84","author":"R Waksman","year":"2017","unstructured":"Waksman R. A new generation of drug-eluting stents: indications and outcomes of bioresorbable vascular scaffolds. Cleve Clin J Med. 2017;84(12 Suppl 4):e20\u20134.","journal-title":"Cleve Clin J Med"},{"issue":"23","key":"1041_CR20","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1016\/j.jacc.2014.09.041","volume":"64","author":"J Wiebe","year":"2014","unstructured":"Wiebe J, Nef HM, Hamm CW. Current status of bioresorbable scaffolds in the treatment of coronary artery disease. J Am Coll Cardiol. 2014;64(23):2541\u201351.","journal-title":"J Am Coll Cardiol"},{"key":"1041_CR21","first-page":"37","volume":"6","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, et al. Bioresorbable scaffolds in the treatment of coronary artery disease. Med Devices (Auckl). 2013;6:37\u201348.","journal-title":"Med Devices (Auckl)"},{"issue":"12","key":"1041_CR22","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.jcin.2014.06.016","volume":"7","author":"Y Onuma","year":"2014","unstructured":"Onuma Y, et al. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B trial (a clinical evaluation of the bioabsorbable Everolimus eluting coronary stent system in the treatment of patients with De novo native coronary artery lesions). JACC Cardiovasc Interv. 2014;7(12):1400\u201311.","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"1041_CR23","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/ccd.26055","volume":"86","author":"M Pichette","year":"2015","unstructured":"Pichette M, Chevalier F, Genereux P. Coronary artery perforation at the level of two-overlapping bioresorbable vascular scaffolds: the importance of vessel sizing and scaffold thickness. Catheter Cardiovasc Interv. 2015;86(4):686\u201391.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"24","key":"1041_CR24","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1056\/NEJMoa1614954","volume":"376","author":"JJ Wykrzykowska","year":"2017","unstructured":"Wykrzykowska JJ, et al. Bioresorbable scaffolds versus metallic stents in routine PCI. N Engl J Med. 2017;376(24):2319\u201328.","journal-title":"N Engl J Med"},{"issue":"23","key":"1041_CR25","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1016\/j.jacc.2017.10.010","volume":"70","author":"DJ Kereiakes","year":"2017","unstructured":"Kereiakes DJ, et al. 3-year clinical outcomes with Everolimus-eluting Bioresorbable coronary scaffolds: the ABSORB III trial. J Am Coll Cardiol. 2017;70(23):2852\u201362.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1041_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4244\/EIJV15I1A5","volume":"15","author":"A Mangieri","year":"2019","unstructured":"Mangieri A, Colombo A. Should we stop using bioresorbable scaffolds in coronary revascularisation? EuroIntervention. 2019;15(1):28\u201330.","journal-title":"EuroIntervention"},{"issue":"2","key":"1041_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"FJ Neumann","year":"2019","unstructured":"Neumann FJ, et al. 2018 ESC\/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87\u2013165.","journal-title":"Eur Heart J"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-020-1041-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13019-020-1041-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-020-1041-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:22:38Z","timestamp":1611706958000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-020-1041-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,28]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1041"],"URL":"https:\/\/doi.org\/10.1186\/s13019-020-1041-5","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,28]]},"assertion":[{"value":"19 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We declare that we do not have any commercial or associative interest that represents a conflict of interest in connection with the work submitted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}